Avanos Medical (AVNS) Other Accumulated Expenses (2017 - 2018)

Avanos Medical (AVNS) reported Other Accumulated Expenses of $34.1 million for Q3 2018, up 16.78% sequentially from $29.2 million in Q4 2017.

Avanos Medical (AVNS) Other Accumulated Expenses (2017 - 2018) Analysis & Trends

Avanos Medical (AVNS) has 2 years of Other Accumulated Expenses data on file, last reported at $34.1 million in Q3 2018.

For the quarter ending Q3 2018, Other Accumulated Expenses changed N/A year-over-year to $34.1 million; the trailing twelve-month figure through Sep 2018 stood at $34.1 million (changed N/A YoY), and the FY2017 full-year result was $29.2 million, changed N/A from the prior year.
Other Accumulated Expenses improved to $34.1 million in Q3 2018, from $29.2 million in the prior quarter.
In the past five years, Other Accumulated Expenses ranged from a high of $34.1 million in Q3 2018 to a low of $29.2 million in Q4 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	183.54 Bn	176.25 Bn	6.27 Bn
2	Stryker	128.93 Bn	126.05 Bn	3.81 Bn
3	Medtronic	108.84 Bn	99.62 Bn	6.41 Bn
4	Boston Scientific	68.42 Bn	66.96 Bn	3.61 Bn
5	Edwards Lifesciences	47.32 Bn	43.65 Bn	1.29 Bn
6	GE HealthCare Technologies	28.46 Bn	26.18 Bn	1.98 Bn
7	Dexcom	28.46 Bn	27.34 Bn	750.30 Mn
8	Smith & Nephew	26.97 Bn	26.40 Bn	-
9	Koninklijke Philips	25.55 Bn	22.42 Bn	2.07 Bn
10	Avanos Medical	1.16 Bn	1.10 Bn	94.20 Mn

Download Data

Date	Value
Sep 30, 2018	34.10 Mn
Dec 31, 2017	29.20 Mn